Author Question: Suppose the market demand elasticity is constant at -2, and there are three identical firms in the ... (Read 127 times)

Medesa

  • Hero Member
  • *****
  • Posts: 507
Suppose the market demand elasticity is constant at -2, and there are three identical firms in the oligopolistic market. A Cournot firm's MPL = 1.2L-0.5, then the labor demand for a Cournot firm is
 
  A) PL-0.5.
  B) 0.6PL-0.5.
  C) 0.2PL-2.
  D) PL-2.

Question 2

Suppose the demand for widgets is given by QD = 100 - 5p - pd + 2Y, where Y is average consumer income, p is the price of lemons, and pd is the price of doodads. According to this equation, widgets are an inferior good.
 
  Indicate whether the statement is true or false



cloud

  • Sr. Member
  • ****
  • Posts: 343
Answer to Question 1

A

Answer to Question 2

False . As income increases, because of the positive coefficient (+2 ) for income, demand will increase. This indicates widgets are normal.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

ACTH levels are normally highest in the early morning (between 6 and 8 A.M.) and lowest in the evening (between 6 and 11 P.M.). Therefore, a doctor who suspects abnormal levels looks for low ACTH in the morning and high ACTH in the evening.

Did you know?

Hyperthyroidism leads to an increased rate of metabolism and affects about 1% of women but only 0.1% of men. For most people, this increased metabolic rate causes the thyroid gland to become enlarged (known as a goiter).

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library